Skip to content

Long-term Stability and Survival Rates of a Novel Oticon Medical Bone Conduction Device Implant

Long-term Stability and Survival Rates of a Novel Oticon Medical Bone Conduction Device Implant

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01738490
Enrollment
59
Registered
2012-11-30
Start date
2012-06-30
Completion date
2016-12-31
Last updated
2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deafness, Ear Diseases, Hearing Disorders, Hearing Loss, Hearing Loss, Conductive, Otorhinolaryngologic Diseases

Keywords

Bone anchored hearing aid, Bone anchored implant, Implant stability, Wide diameter implant, Linear incision, Ponto

Brief summary

The overall aim of the study is to investigate the Ponto wide implant considering; initial implant stability, stability over time, skin reaction and long term success when loaded at 3 weeks post surgery. Patients' quality of life improvements following implantation will also be surveyed. More specifically the primary objective of this clinical study is to test the hypothesis * The new Ponto wide diameter implant offers increased implant stability measured as ISQ (implant stability quotient) compared to the previous generation Ponto implant. And the secondary objective is to * Investigate when in time implant stability is the lowest as the initial mechanical stability is gradually replaced by biological stability

Interventions

DEVICEBone anchored hearing implant

Sponsors

Oticon Medical
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older * Patient indicated for an ear level bone anchored sound processor * Bone thickness at the implant site of at least 4 mm

Exclusion criteria

* Longer abutment (\>6mm) required * Inability to participate in follow-up * Psychiatric disease in the medical history * Mental disability * Presumed doubt, for any reason, that the patient will be able to show up on all follow ups * Diseases or treatments known to compromise the bone quality at the implant site, e.g. radiotherapy, osteoporosis, diabetes mellitus.

Design outcomes

Primary

MeasureTime frameDescription
ISQ (Implant Stability Quotient)Surgery (0 days)ISQ (implant Stability Quotient) is a measurement scale for use with the Resonance Frequency Analysis (RFA) method of determining implant stability. The measurement is made using the Osstell Mentor equipment (Osstell, Sweden) with SmartPegs. ISQ values range from 1 to 100, the higher the score the higher the stability. The highest and lowest score obtained from perpendicular measurements will be registered.

Secondary

MeasureTime frameDescription
ISQ (Implant stability quotient) gradient0, 7, 14, 21 and 28 days, 6 weeks, 12weeks, 6 months after surgeryISQ (implant stability quotient) per time unit gives a measure of osseointegration speed.
Skin condition according to Holgers score7 days after surgeryHolgers score is a standardized scale to clinically assess skin condition around a percutaneous implant
Time of minimum ISQ (Implant stability quotient)0, 7, 14, 21 and 28 days after surgeryImplant stability can be seen as a combination of mechanical stability, which is the result of compressed bone holding the implant tightly in place, and biological stability, which is the result of new bone forming at the site of implantation and osseointegration. Mechanical stability is generally high immediately after implant placement and is decreasing with time. Biological stability, on the other hand, is non-existent immediately after placement and increases with time. The final stability level for an implant is the sum of the two. There is likely to be an initial decrease in stability followed by a subsequent increase as the implant becomes biologically stable. ISQ (implant Stability Quotient) is a measurement scale for use with the Resonance Frequency Analysis (RFA) method of determining implant stability.
Abbreviated Profile of Hearing Aid Benefit (APHAB) questionnaireBefore surgeryThe APHAB is a 24-item self-assessment inventory in which patients report the amount of trouble they are having with communication or noises in various everyday situations. Benefit is calculated by comparing the patient's reported difficulty in the unaided condition with their amount of difficulty when using amplification. The APHAB produces scores for 4 subscales: Ease of Communication (EC), Reverberation (RV), Background Noise (BN), and Aversiveness (AV).
Glasgow Health Status Inventory (GHSI) questionnaireBefore surgeryThe Glasgow Health Status Inventory is an 18 item questionnaire. It assesses health state, by measuring the effect of a health problem on the quality of life of a person. It allows cross-comparison among many health conditions, among different health interventions, and among demographic and cultural subgroups.
Glasgow Benefit Inventory Questionnaire3 months after surgeryGlasgow Benefit Inventory Questionnaire (GBI) 18-item, post-surgical questionnaire given to patients. The GBI measures the change in health status produced by surgical interventions (here, health status is the general perception of well-being, including total psychological, social, and physical well being).

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026